69 results
8-K
EX-4.2
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company … sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any
8-K
EX-10.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.
(bb) Tax Status. Except … Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports
8-K
EX-4.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes … , as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer
8-K
EX-4.3
dhaop 02n0y
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
424B5
f9ug6uvjwgdt7hj
5 Feb 24
Prospectus supplement for primary offering
4:34pm
PRE 14A
hhes7djm48 que0z
13 Sep 23
Preliminary proxy
5:14pm
8-K
EX-99.1
jpumphd0
10 Aug 23
NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:06pm
8-K
EX-99.1
plsw6koz4o1bcp58j
15 May 23
NexImmune Reports First Quarter 2023 Financial Results and Provides Business Updates
4:03pm
8-K
EX-99.1
k4ui4i
14 Nov 22
NexImmune Reports Third Quarter 2022 Financial Results and Announces Strategic Update
4:11pm